Aridis Pharmaceuticals, Inc.

( )
ARDS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 2.54%53.730.9%$2578.87m
JNJJohnson & Johnson -2.37%155.960.7%$1216.03m
MRKMerck & Co., Inc. 0.00%74.890.7%$1134.23m
LLYEli Lilly & Co. -2.55%248.341.1%$731.87m
BMYBristol-Myers Squibb Co. -1.85%53.631.0%$692.49m
ABBVAbbVie, Inc. -1.41%115.241.9%$609.56m
AZNAstraZeneca Plc -1.26%54.831.0%$288.05m
NVSNovartis AG -0.72%79.690.2%$175.76m
GSKGlaxoSmithKline Plc -0.56%41.130.2%$174.09m
VTRSViatris, Inc. -1.68%12.310.0%$138.06m
DRNADicerna Pharmaceuticals, Inc. -0.18%38.010.3%$135.01m
BFRIBiofrontera, Inc. -15.63%5.990.0%$129.02m
RPRXRoyalty Pharma Plc -3.80%39.770.1%$117.73m
RGENRepligen Corp. -1.61%286.506.7%$114.53m
PTPIPetros Pharmaceuticals, Inc. -28.50%2.860.0%$96.83m

Company Profile

Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections. Its products include AR-301, AR-101, AR-501, AR-712, AR-701, AR-401, AR-105 and AR-201. The company was founded by Eric J. Patzer and Vu L. Truong in 2003 and is headquartered in Los Gatos, CA.